169 related articles for article (PubMed ID: 17097888)
1. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome.
Meechan DW; Maynard TM; Wu Y; Gopalakrishna D; Lieberman JA; LaMantia AS
Mol Cell Neurosci; 2006 Dec; 33(4):412-28. PubMed ID: 17097888
[TBL] [Abstract][Full Text] [Related]
2. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome.
Meechan DW; Tucker ES; Maynard TM; LaMantia AS
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16434-45. PubMed ID: 19805316
[TBL] [Abstract][Full Text] [Related]
3. When half is not enough: gene expression and dosage in the 22q11 deletion syndrome.
Meechan DW; Maynard TM; Gopalakrishna D; Wu Y; LaMantia AS
Gene Expr; 2007; 13(6):299-310. PubMed ID: 17708416
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome.
Prescott K; Ivins S; Hubank M; Lindsay E; Baldini A; Scambler P
Hum Genet; 2005 May; 116(6):486-96. PubMed ID: 15778864
[TBL] [Abstract][Full Text] [Related]
5. In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?
Motahari Z; Moody SA; Maynard TM; LaMantia AS
J Neurodev Disord; 2019 Jun; 11(1):7. PubMed ID: 31174463
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of 22q11 gene expression in the developing and adult brain.
Maynard TM; Haskell GT; Peters AZ; Sikich L; Lieberman JA; LaMantia AS
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14433-8. PubMed ID: 14614146
[TBL] [Abstract][Full Text] [Related]
7. Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome.
Karpinski BA; Maynard TM; Fralish MS; Nuwayhid S; Zohn IE; Moody SA; LaMantia AS
Dis Model Mech; 2014 Feb; 7(2):245-57. PubMed ID: 24357327
[TBL] [Abstract][Full Text] [Related]
8. Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes.
Meechan DW; Maynard TM; Tucker ES; LaMantia AS
Int J Dev Neurosci; 2011 May; 29(3):283-94. PubMed ID: 20833244
[TBL] [Abstract][Full Text] [Related]
9. 22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development.
Maynard TM; Gopalakrishna D; Meechan DW; Paronett EM; Newbern JM; LaMantia AS
Hum Mol Genet; 2013 Jan; 22(2):300-12. PubMed ID: 23077214
[TBL] [Abstract][Full Text] [Related]
10. Ranbp1 modulates morphogenesis of the craniofacial midline in mouse models of 22q11.2 deletion syndrome.
Paronett EM; Bryan CA; Maynard ME; Goroff JA; Meechan DW; LaMantia AS; Maynard TM
Hum Mol Genet; 2023 Jun; 32(12):1959-1974. PubMed ID: 36790128
[TBL] [Abstract][Full Text] [Related]
11. Goosecoid-like, a gene deleted in DiGeorge and velocardiofacial syndromes, recognizes DNA with a bicoid-like specificity and is expressed in the developing mouse brain.
Gottlieb S; Hanes SD; Golden JA; Oakey RJ; Budarf ML
Hum Mol Genet; 1998 Sep; 7(9):1497-505. PubMed ID: 9700206
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit.
Berti L; Mittler G; Przemeck GK; Stelzer G; Günzler B; Amati F; Conti E; Dallapiccola B; Hrabé de Angelis M; Novelli G; Meisterernst M
Genomics; 2001 Jun; 74(3):320-32. PubMed ID: 11414760
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of hippocampal dentate granule neuron genes in a mouse model of human 22q11 deletion syndrome.
Jurata LW; Gallagher P; Lemire AL; Charles V; Brockman JA; Illingworth EL; Altar CA
Schizophr Res; 2006 Dec; 88(1-3):251-9. PubMed ID: 17008057
[TBL] [Abstract][Full Text] [Related]
14. The murine homologue of HIRA, a DiGeorge syndrome candidate gene, is expressed in embryonic structures affected in human CATCH22 patients.
Wilming LG; Snoeren CA; van Rijswijk A; Grosveld F; Meijers C
Hum Mol Genet; 1997 Feb; 6(2):247-58. PubMed ID: 9063745
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional dysregulation in developing trigeminal sensory neurons in the LgDel mouse model of DiGeorge 22q11.2 deletion syndrome.
Maynard TM; Horvath A; Bernot JP; Karpinski BA; Tavares ALP; Shah A; Zheng Q; Spurr L; Olender J; Moody SA; Fraser CM; LaMantia AS; Lee NH
Hum Mol Genet; 2020 Apr; 29(6):1002-1017. PubMed ID: 32047912
[TBL] [Abstract][Full Text] [Related]
16. Goosecoid-like (Gscl), a candidate gene for velocardiofacial syndrome, is not essential for normal mouse development.
Saint-Jore B; Puech A; Heyer J; Lin Q; Raine C; Kucherlapati R; Skoultchi AI
Hum Mol Genet; 1998 Nov; 7(12):1841-9. PubMed ID: 9811927
[TBL] [Abstract][Full Text] [Related]
17. The 22q11.2 deletion syndrome: a gene dosage perspective.
Baldini A
ScientificWorldJournal; 2006 May; 6():1881-7. PubMed ID: 17205194
[TBL] [Abstract][Full Text] [Related]
18. Ranbp1, Deleted in DiGeorge/22q11.2 Deletion Syndrome, is a Microcephaly Gene That Selectively Disrupts Layer 2/3 Cortical Projection Neuron Generation.
Paronett EM; Meechan DW; Karpinski BA; LaMantia AS; Maynard TM
Cereb Cortex; 2015 Oct; 25(10):3977-93. PubMed ID: 25452572
[TBL] [Abstract][Full Text] [Related]
19. System-based proteomic and metabonomic analysis of the Df(16)A
Wesseling H; Xu B; Want EJ; Holmes E; Guest PC; Karayiorgou M; Gogos JA; Bahn S
Mol Psychiatry; 2017 Mar; 22(3):384-395. PubMed ID: 27001617
[TBL] [Abstract][Full Text] [Related]
20. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
